O. Perez

Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector

Harry E. Gruber, Joan M. Robbins, J. Hlavaty, 2011, Neuro-oncology.

Design and selection of Toca 511 for clinical use: modified retroviral replicating vector with improved stability and gene expression.

D. Lohse, K. Hiraoka, N. Kasahara, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Intratumoral conversion of flucytosine to 5-fluorouracil using a novel MLV-based replication-competent retroviral vector carrying the cytosine deaminase gene (Toca 511) in an immune-competent model of glioblastoma.

W. Günzburg, H. Gruber, J. Robbins, 2010 .

Erratum: Design and selection of toca 511 for clinical use: Modified retroviral replicating vector with improved stability and gene expression (Molecular Therapy (2012) 20 (1689-1698) DOI:10.1038/mt.2012.83)

D. Lohse, K. Hiraoka, N. Kasahara, 2013 .